Cargando...

P08.55 δ-catenin modulates bevacizumab-induced glioma invasion

Introduction: Data showing that bevacizumab in combination with temozolomide and radiotherapy improved progression-free survival in patients with newly diagnosed glioblastoma have highlighted the potential of bevacizumab as a glioma therapy. However, while bevacizumab potently suppresses angiogenesi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Shimizu, T., Kurozumi, K.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464067/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.244
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!